Ipilimumab vs Lovastatin
Ipilimumab vs Lovastatin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lovastatin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lovastatin: First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Lovastatin — 2-3 hours.
Chemical Properties
Molecular Formula: Lovastatin — C24H36O5.
Molecular Weight: Lovastatin — 404.5390 g/mol.
Type: Ipilimumab — Antibody; Lovastatin — Small molecule.